Related Experiment Video
Updated: Nov 11, 2025

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
Diastolic blood pressure is associated with brain atrophy in hemodialysis patients: A single center case-control
Keren Cohen-Hagai1,2, Feda Fanadka3, Tania Grumberg4
1Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba, Israel.
Insights
Lower diastolic blood pressure (DBP) is linked to increased brain atrophy (BA) in hemodialysis patients, suggesting cerebral hypoperfusion. This finding advises against aggressive hypertension treatment in this population.
Area of Science:
- Nephrology
- Neurology
- Radiology
Background:
- Brain atrophy (BA) is common in hemodialysis patients, indicating cerebral damage.
- Factors like age, hypertension, and diabetes contribute to BA, often present in hemodialysis patients.
- Cerebral hypoperfusion during hemodialysis may also cause BA, but optimal blood pressure targets are unclear.
Purpose of the Study:
- To investigate the association between blood pressure (BP) levels and the prevalence/severity of brain atrophy in hemodialysis patients.
- To determine if lower BP is associated with a higher incidence or greater severity of BA.
Main Methods:
- Retrospective study of 280 patients undergoing brain CT scans (2015-2017).
- BA was graded by a blinded neuroradiologist.
- Hemodialysis patients were compared to age- and sex-matched controls with normal kidney function.
Main Results:
- Brain atrophy was more prevalent in hemodialysis patients and worsened with age and cardiovascular risk factors.
- A significant negative correlation was found between diastolic blood pressure (DBP) at dialysis initiation and BA severity.
- Lower average DBP correlated with increased BA severity in both hemodialysis and non-CKD patients.
Conclusions:
- Lower DBP is associated with increased brain atrophy, potentially due to cerebral hypoperfusion and ischemia.
- Findings suggest that over-treatment of hypertension in hemodialysis patients should be reconsidered.
Abstract:
Brain atrophy (BA) is often found in neuroimaging of hemodialysis patients, representing parenchymal cerebral damage. Likely contributing factors to BA are age, chronic hypertension, diabetes mellitus and other cardiovascular risk factors of atherosclerosis that are also common among hemodialysis patients. BA may also occur due to focal ischemia and hypoperfusion during hemodialysis. However, data on optimal blood pressure (BP) in these patients are limited. The goal of this study was to determine whether the prevalence and severity of BA would be higher among hemodialysis patients with lower BP. A blinded neuroradiologist graded BA of all hemodialysis patients who underwent brain non-contrast computerized tomography (CT) from 2015 to 2017 in our institution. Age- and sex-matched patients with normal kidney function who underwent brain CT during the same period and technique served as the control group. A total of 280 patients were included in this retrospective study, with average BP of 140/70 mmHg among hemodialysis patients and 142/75 mmHg in the control group. BA was more common in dialysis patients and its severity increased with age and traditional cardiovascular risk factors. We observed a significant negative correlation between diastolic BP (DBP) at dialysis initiation and BA. Average DBP decreased with increasing severity of BA. These findings were observed in both hemodialysis and non-CKD patients. BA was associated with lower DBP, which may induce cerebral hypoperfusion and ischemia. This finding should discourage over-treatment of hypertension among hemodialysis patients.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Hemodialysis II: Procedure and Complications
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Hypertension II: Pathophysiology

